The African Centre for Biodiversity (ACB), a Johannesburg-based advocacy group, says its testing found glyphosate residues in baby cereals sold across South Africa and is calling for an immediate ban on the herbicide. The group’s report focuses on products marketed to infants. ACB also points to peer-reviewed animal research on glyphosate exposure and to the retraction of a frequently cited 2000 safety review as reasons regulators should reassess existing safety assumptions.
What the Baby Cereal Tests Revealed
The ACB’s testing campaign focused on widely available infant cereal brands in South Africa. The group reported detectable glyphosate residues in products consumed daily by children during a critical window of development. While the ACB has framed the findings as evidence of regulatory failure, the absence of publicly released raw lab data or detailed methodology limits independent verification of the exact residue levels. The ACB report did not cite a formal response from South African authorities.
The ACB argues this matters because, in its view, oversight and residue-limit enforcement for infant foods is not as explicit or protective as in some other markets. For parents buying cereal off supermarket shelves, the practical effect is a gap between what is on the label and what may be in the box.
Rat Study Links Low Doses to Tumor Growth
The ACB’s call for a ban draws heavily on a peer-reviewed investigation known as the Global Glyphosate Study, published in the journal Environmental Health by Springer Nature. In that long-term experiment, described in detail in a recent article, Sprague-Dawley rats were exposed to glyphosate and glyphosate-based herbicides from prenatal life through 104 weeks. The doses were aligned to the European Union’s acceptable daily intake, meaning the animals received amounts that regulators currently consider safe for human consumption.
The results challenge that assumption directly. Researchers reported statistically significant dose-related increases and trends in both benign and malignant tumors across multiple organ sites. Because the exposure began before birth and continued through the animals’ natural lifespan, the study was designed to examine chronic, low-level exposure over time. The findings do not prove that glyphosate causes cancer in humans, but the authors said the results raise questions about whether existing “acceptable” exposure thresholds are sufficiently protective.
IARC’s Cancer Classification Still Drives Policy Fights
The scientific tension around glyphosate is not new. The International Agency for Research on Cancer, a specialized body within the World Health Organization, classified glyphosate as probably carcinogenic to humans under its Group 2A designation. That judgment followed a systematic review conducted by an expert Working Group and has since become one of the most cited pieces of evidence in global advocacy campaigns seeking to restrict or ban the herbicide.
Regulatory agencies in the United States and Europe have not uniformly adopted IARC’s position. The U.S. Environmental Protection Agency, for instance, has maintained that glyphosate is not likely to be carcinogenic to humans at levels relevant to human health. That split between IARC and national regulators has created a policy vacuum that countries like South Africa fall into. Without a strong domestic risk-assessment apparatus, South African authorities have largely deferred to international safety benchmarks that are themselves contested.
IARC’s evaluation, documented across its long-running monograph programme, is part of a broader ecosystem of cancer-hazard resources, including specialized prevention handbooks, occupational exposure databases such as the CAREX registry, and detailed tumor classification references like the WHO Blue Books. Together, these tools are designed to help regulators and clinicians evaluate evidence on cancer hazards and prevention. The ACB cites IARC’s work as support for a more precautionary approach to glyphosate regulation.
The Retracted Study That Shaped Decades of Policy
One of the most damaging details in the ACB’s argument concerns the regulatory history itself. For years, a safety evaluation published in 2000 by Williams, Kroes, and Munro in the journal Regulatory Toxicology and Pharmacology served as a foundational reference for agencies approving glyphosate use. That paper concluded the herbicide posed minimal risk to human health, and the ACB says it was widely cited in regulatory discussions about glyphosate safety.
The paper now carries a formal retraction notice on its PubMed record. A retraction does not automatically invalidate every conclusion in a study, but it signals serious concerns about the integrity of the research, its methodology, or potential conflicts of interest. The retraction means the journal has withdrawn the paper from the scientific record; the extent to which any particular regulator relied on it varies by jurisdiction and would require case-by-case review. For South African regulators who may have inherited those determinations without conducting independent reviews, the retraction should prompt a reassessment of domestic glyphosate tolerances, particularly for foods consumed by infants.
Why Developing Markets Face Higher Risk
The ACB report exposes a structural problem that extends beyond any single herbicide. Countries with limited food-safety testing infrastructure tend to import regulatory conclusions from wealthier nations rather than generating their own data. When those imported conclusions turn out to be based on retracted or contested science, the downstream effects are magnified in markets where monitoring is sparse and enforcement is weak.
South Africa’s agricultural sector relies heavily on glyphosate for weed control in maize and other staple crops. Maize is a primary ingredient in many commercial baby cereals. The supply chain from field to infant bowl is short and direct, which means that any contamination at the agricultural stage has a clear path to the consumer. In wealthier markets, tighter residue limits and more frequent testing create at least a partial filter. In South Africa, that filter is thinner.
The ACB’s demand for a ban also reflects a broader pattern across the African continent, where civil society groups have increasingly pushed back against the adoption of agricultural chemicals approved under regulatory frameworks designed in and for different economic contexts. The argument is not simply that glyphosate is dangerous in the abstract, but that the risk calculus changes in environments where farmers have less access to protective equipment, regulators conduct fewer random tests, and consumers have limited options to switch to organic or specialty products.
What Stronger Oversight Could Look Like
Short of an outright ban, public-health advocates point to several measures that could reduce potential harm. One is the establishment of infant-specific maximum residue limits for pesticides in baby foods, aligned with the most protective international standards rather than the most permissive. Another is mandatory, transparent testing of high-consumption products like cereals, with results published in formats that parents and pediatricians can understand.
Regulators could also require clearer labeling of raw-material sourcing, allowing independent researchers to trace contamination back to particular growing regions or farming practices. Over time, such traceability could create market incentives for producers who adopt lower-chemical or glyphosate-free cultivation methods. For South Africa, where export agriculture is economically important, aligning domestic standards with the stricter expectations emerging in some trading partners could also protect long-term market access.
Parents Caught Between Science and Uncertainty
For families reading headlines about glyphosate in baby cereal, the immediate question is practical: what should they do now? Nutrition experts generally caution against abrupt, unplanned changes to an infant’s diet, especially in regions where alternative products may be scarce or unaffordable. At the same time, the combination of a contested carcinogen, a retracted safety study, and a lack of local residue limits makes it difficult to reassure parents that existing products are unquestionably safe.
In that uncertainty, the ACB is pushing for a precautionary approach: restrict or phase out glyphosate use, especially on crops destined for infant foods, until independent, transparent testing demonstrates that exposure levels are genuinely negligible. Whether South African regulators embrace that stance or continue to lean on older, now-questioned assessments will determine not only the future of one herbicide, but also the credibility of the country’s wider food-safety system.
More from Morning Overview
*This article was researched with the help of AI, with human editors creating the final content.
